AnaptysBio Inc (ANAB)

AnaptysBio (ANAB) Financial Statements


AnaptysBio Financial Overview

AnaptysBio's market cap is currently ―. The company's EPS TTM is $-5.413; its P/E ratio is -3.02; AnaptysBio is scheduled to report earnings on March 4, 2024, and the estimated EPS forecast is $-1.58. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.32M$ 3.46M$ 1.37M$ 6.81M$ 1.29M
Gross Profit$ 3.32M$ 3.46M$ 1.37M$ 6.81M-
EBIT$ -37.31M$ -39.84M$ -44.26M$ -25.98M$ -27.37M
EBITDA$ -39.71M$ -41.44M$ -45.85M$ -25.37M$ -26.78M
Net Income Common Stockholders$ -37.31M$ -39.84M$ -44.26M$ -26.37M$ -33.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 413.05M$ 429.49M$ 431.15M$ 441.24M$ 442.97M
Total Assets$ 487.33M$ 517.10M$ 549.81M$ 610.38M$ 618.50M
Total Debt$ 18.23M$ 18.65M$ 19.06M$ 19.45M$ 19.84M
Net Debt$ -394.81M$ -410.83M$ -412.09M$ -421.79M$ -423.13M
Total Liabilities$ 366.94M$ 368.65M$ 360.70M$ 348.28M$ 340.88M
Stockholders Equity$ 120.38M$ 148.45M$ 191.09M$ 262.10M$ 277.62M
Cash Flow-
Free Cash Flow$ -36.64M$ -25.60M$ -24.74M$ -10.86M$ -17.80M
Operating Cash Flow$ -36.47M$ -25.41M$ -24.57M$ -10.69M$ -17.75M
Investing Cash Flow$ 30.64M$ -20.45M$ 85.40M$ 21.50M$ -32.43M
Financing Cash Flow$ -3.07M$ -13.49M$ -37.57M$ 1.95M$ 37.03M
Currency in USD

AnaptysBio Earnings and Revenue History

AnaptysBio Debt to Assets

AnaptysBio Cash Flow

AnaptysBio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis